Infections with VIM-1 Metallo-β-Lactamase-Producing Enterobacter cloacae and Their Correlation with Clinical Outcome
- 1 November 2009
- journal article
- research article
- Published by American Society for Microbiology in Journal of Clinical Microbiology
- Vol. 47 (11) , 3514-3519
Abstract
The aim of this study was to ascertain the incidence and clinical significance of metallo-β-lactamases among Enterobacter strains isolated from patients with nosocomial infections. We prospectively collected data on patients with Enterobacter infection during a 13-month period. All of the strains were investigated for antibiotic susceptibility, the presence and expression of metallo-β-lactamases, and clonality. Of 29 infections (11 involving the urinary tract, 7 pneumonias, 3 skin/soft tissue infections, 3 intra-abdominal infections, 3 bacteremias, and 2 other infections), 7 (24%) were caused by Enterobacter cloacae strains harboring a bla VIM-1 gene associated or not with a bla SHV12 gene. Infections caused by VIM-1-producing strains were more frequently associated with a recent prior hospitalization ( P = 0.006), cirrhosis ( P = 0.03), relapse of infection ( P < 0.001), and more prolonged duration of antibiotic therapy ( P = 0.01) than were other infections. All of the isolates were susceptible to imipenem and meropenem and had bla VIM-1 preceded by a weak P1 promoter and inactivated P2 promoters. Most VIM-1-producing Enterobacter isolates belonged to a main clone, but four different clones were found. Multiclonal VIM-1-producing E. cloacae infections are difficult to diagnose due to an apparent susceptibility to various beta-lactams, including carbapenems, and are associated with a high relapse rate and a more prolonged duration of antibiotic therapy.Keywords
This publication has 29 references indexed in Scilit:
- Prolonged bacteraemia caused by VIM-1 metallo-β-lactamase-producing Proteus mirabilis: first report from ItalyClinical Microbiology and Infection, 2010
- First Countrywide Survey of Acquired Metallo-β-Lactamases in Gram-Negative Pathogens in ItalyAntimicrobial Agents and Chemotherapy, 2008
- CDC/NHSN surveillance definition of health care–associated infection and criteria for specific types of infections in the acute care settingAmerican Journal of Infection Control, 2008
- Outbreak of Acinetobacter baumannii with Chromosomally Encoded VIM-1 Undetectable by Imipenem-EDTA Synergy TestsAntimicrobial Agents and Chemotherapy, 2008
- Clinical Experience of Serious Infections Caused by Enterobacteriaceae Producing VIM-1 Metallo- -Lactamase in a Greek University HospitalClinical Infectious Diseases, 2008
- E240V Substitution Increases Catalytic Efficiency toward Ceftazidime in a New Natural TEM-Type Extended-Spectrum β-Lactamase, TEM-149, from Enterobacter aerogenes and Serratia marcescens Clinical IsolatesAntimicrobial Agents and Chemotherapy, 2008
- Evaluation of phenotypic tests for the detection of metallo- -lactamase-producing Pseudomonas aeruginosa in a low prevalence countryJournal of Antimicrobial Chemotherapy, 2008
- Hidden VIM-1 Metallo-β-Lactamase Phenotypes among Acinetobacter baumannii Clinical IsolatesJournal of Clinical Microbiology, 2008
- Bloodstream infections caused by multidrug-resistant Klebsiella pneumoniae producing the carbapenem-hydrolysing VIM-1 metallo- -lactamase: first Italian outbreakJournal of Antimicrobial Chemotherapy, 2007
- Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock: 2008Intensive Care Medicine, 2007